PetMed Express (PETS) Q4 2025: 66% Inventory Cut Resets Cost Base as Growth Turns Elusive
PetMed Express executed a deep inventory rationalization and cost reset, but revenue trends remain sharply negative as customer acquisition and marketing pullbacks weigh on growth. Management’s focus is on building a modernized digital platform and customer experience to capture younger demographics, but near-term sales softness and competitive intensity create a challenging turnaround path. Investors should watch for traction in customer conversion and marketing ROI as the company prepares for more aggressive acquisition efforts ahead.
Summary
- Inventory Overhaul: PETS slashed inventory by 66%, signaling aggressive cost discipline and SKU optimization.
- Growth Headwinds Persist: Revenue declines continue as marketing cutbacks and customer mix shifts weigh on top line.
- Turnaround Hinges on Execution: Success depends on digital upgrades and recapturing new customer momentum in a competitive pet health market.
Business Overview
PetMed Express is a digital retailer specializing in prescription and non-prescription pet medications, health products, and pet wellness solutions. The company generates revenue primarily through direct-to-consumer e-commerce sales, serving pet owners and partnering with veterinarians. Its business is structured around three core communities: pet parents, veterinary partners, and the pets themselves, with pharmacy (Rx), over-the-counter (OTC), and food categories as key segments.
Performance Analysis
PetMed Express delivered a quarter marked by sharp cost containment and operational restructuring, but revenue contraction remained steep. Net sales dropped meaningfully year over year, driven by a deliberate 34% reduction in advertising spend as management prioritized margin protection over promotional activity during a highly competitive holiday season. Despite this, gross profit margin improved modestly, reflecting a more favorable sales mix and reduced discounting.
The company’s operational reset included a 66% reduction in inventory and the elimination of 4,000 underperforming SKUs, which management emphasized had minimal impact on revenue but improved inventory efficiency. General and administrative expenses fell nearly 20%, and adjusted EBITDA doubled year over year, underscoring the impact of cost actions. However, customer acquisition remains a pain point, with 63,000 new shipped-order customers but overall sales and order volumes still under pressure. The company’s call center modernization and digital upgrades yielded higher sales per agent and improved average order value, but these gains have yet to offset broader top-line declines.
- Cost Discipline: G&A and advertising spend reductions drove improved EBITDA despite revenue headwinds.
- Inventory Efficiency: Inventory turn improved to 1.5x, reflecting SKU rationalization and working capital release.
- Customer Acquisition Strain: Pullback in marketing spend led to weaker new customer growth and softer sales during the key holiday period.
While operational execution on cost and margin is evident, the core challenge remains reigniting sustainable growth in a competitive, evolving pet health market.
Executive Commentary
"Our highest priority has been to return the company to profitability. We achieved this by implementing cost-cutting measures and consolidation strategies to integrate PetCareRx operations into the PetMeds organization, targeting $5 million in annualized savings, and we remain on track to meet this milestone."
Sandra Campos, Chief Executive Officer & President
"Our advertising expenses for the third quarter were $3 million compared to $5.8 million last year. This decrease can be mainly attributed to lower gross media spend and a higher proportion of that spend being funded by third-party partners. As Sandra mentioned, we purposely pulled back our marketing efforts to reset our marketing foundation and improve profitability for the quarter."
Robin, Chief Financial Officer
Strategic Positioning
1. Inventory and SKU Rationalization
PETS aggressively reduced inventory by 66% and eliminated 4,000 underperforming SKUs, focusing on products with proven sales velocity. This SKU optimization, which targeted items lacking consistent sales, was designed to improve inventory turn and working capital without materially impacting revenue. Management confirmed most cuts were from drop-ship vendors and low-performing categories.
2. Digital Platform Modernization
The company overhauled its website and mobile apps, replatformed its Autoship subscription program, and rolled out Buy Now, Pay Later options, with the goal of attracting younger, digitally-native pet owners. Early signs include higher product detail page views and lower bounce rates, but conversion rates remain an active area of focus as PETS works to translate traffic into orders.
3. Marketing Reset and Brand Investment
Management intentionally pulled back on promotional marketing during a competitive holiday period, instead investing in foundational brand-building through channels like radio, connected TV, and sports partnerships. The company is now refining its acquisition strategy with improved email segmentation and personalization, reporting early gains in email-driven revenue and engagement rates.
4. Call Center and Operational Automation
PETS integrated an AI-driven workforce management tool into its call center, which improved sales per agent and average order value for phone-driven orders. This operational investment aims to boost efficiency and customer experience, supporting the company’s broader digital transformation.
5. Customer Base Diversification
Historically reliant on older, higher-income pet owners, PETS is repositioning to capture millennial and Gen Z customers. Management acknowledges a need to modernize messaging and product assortment to appeal to this segment, which is increasingly treating pets as family and demanding seamless digital experiences.
Key Considerations
PetMed Express’s quarter reflects a business in active turnaround mode, balancing cost discipline with foundational investments to enable future growth. The operational reset has created margin and cash flow stability, but the path to top-line recovery is not yet visible.
Key Considerations:
- Marketing Reacceleration Timing: The company plans to increase marketing spend after resetting its foundation, but the pace and effectiveness of this ramp will be pivotal for customer acquisition and revenue stabilization.
- Conversion Rate Challenges: Despite higher site traffic and engagement, conversion rates have lagged, requiring continued investment in search, product pages, and checkout optimization.
- Competitive Intensity: Management cited a highly promotional environment over the holidays, which may persist and challenge margin protection efforts as PETS seeks to grow share.
- Demographic Transition: The shift toward younger, digitally-savvy customers is central to the strategy, but success will depend on execution in digital experience, assortment, and fulfillment speed.
Risks
PETS faces structural risks from ongoing revenue declines, with customer acquisition pressure and shifting consumer behavior in a highly competitive pet health market. Failure to convert increased site traffic into orders, or to recapture customer momentum with new marketing investment, could prolong top-line weakness. Additionally, execution risk remains as the company integrates technology and operational upgrades while facing margin pressure from industry-wide promotions and evolving consumer expectations for rapid delivery and digital convenience.
Forward Outlook
For the next quarter, PetMed Express signaled:
- Increased investment in customer engagement and acquisition initiatives.
- Continued infrastructure upgrades to support digital and fulfillment capabilities.
For full-year 2025, management did not provide formal guidance, but emphasized:
- Ongoing cost savings from PetCareRx integration, with phase two focused on technology consolidation.
- Strategic marketing reacceleration after foundational resets, aiming for sustainable, profitable growth.
Management highlighted several factors that will shape results:
- Competitive intensity and promotional activity may remain elevated.
- Success in capturing younger demographics and improving conversion rates will be critical.
Takeaways
PetMed Express has reset its cost base and improved operational efficiency, but revenue and customer momentum remain weak as the company navigates a challenging digital transition.
- Operational Reset: Aggressive inventory and cost actions have stabilized margins, but have not yet revived growth.
- Strategic Pivot: The shift toward digital experience and younger customers is underway, but execution on conversion and marketing ROI will determine the turnaround’s success.
- Watch for Marketing Impact: Investors should monitor the upcoming quarters for evidence that renewed marketing investment and digital upgrades are translating into customer and revenue growth.
Conclusion
PetMed Express delivered a disciplined quarter on cost and operational fronts, but the business remains in transition as growth and customer acquisition lag. The next phase will test whether foundational investments and a refined marketing strategy can reignite sustainable top-line expansion in a competitive pet health landscape.
Industry Read-Through
Pet health and digital pharmacy peers face similar pressures: promotional intensity is rising, and customer acquisition costs are climbing as digital-first competitors and traditional retailers invest heavily in fulfillment and experience. Inventory and SKU rationalization is becoming a sector-wide priority to preserve margin and working capital amid demand uncertainty. Companies that can modernize their tech stack, deliver rapid fulfillment, and capture younger pet owners will be best positioned as the industry shifts toward digital and subscription models. PETS’s experience underscores the importance of balancing cost discipline with sustained investment in brand and technology to weather cyclical softness and emerge stronger.